Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Assets (2016 - 2025)

Historic Return on Assets for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Q3 2025 value amounting to 0.06%.

  • Amphastar Pharmaceuticals' Return on Assets fell 400.0% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year decrease of 400.0%. This contributed to the annual value of 0.1% for FY2024, which is 200.0% down from last year.
  • As of Q3 2025, Amphastar Pharmaceuticals' Return on Assets stood at 0.06%, which was down 400.0% from 0.08% recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year Return on Assets high stood at 0.13% for Q2 2022, and its period low was 0.0% during Q1 2021.
  • In the last 5 years, Amphastar Pharmaceuticals' Return on Assets had a median value of 0.1% in 2024 and averaged 0.09%.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Return on Assets plummeted by -1200bps in 2021 and then soared by 1200bps in 2022.
  • Quarter analysis of 5 years shows Amphastar Pharmaceuticals' Return on Assets stood at 0.1% in 2021, then increased by 25bps to 0.12% in 2022, then fell by -26bps to 0.09% in 2023, then increased by 7bps to 0.1% in 2024, then crashed by -36bps to 0.06% in 2025.
  • Its last three reported values are 0.06% in Q3 2025, 0.08% for Q2 2025, and 0.08% during Q1 2025.